The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 524 KB) and Technical Notes (PDF, 756 KB) pages.



Download and Print: Download Printer-friendly PDF Download data


Table 1.11

Age Distribution (%) of Incidence Cases by Site, 2009-2013
All Races, Both Sexes
Site Ages <20 Ages 20-34 Ages 35-44 Ages 45-54 Ages 55-64 Ages 65-74 Ages 75-84 Ages 85+ All Ages Number of Cases
All Sites 1.0 2.7 5.1 13.8 24.4 26.2 18.8 7.9 100.0% 2,040,923
Oral Cavity & Pharynx: 0.5 2.0 5.1 18.8 30.5 22.9 14.0 6.1 100.0% 51,827
Lip 0.2 1.3 4.6 15.1 20.7 23.3 21.7 13.1 100.0% 3,044
Tongue 0.1 1.7 4.5 18.4 33.3 24.5 12.8 4.6 100.0% 15,450
Salivary gland 2.2 5.8 7.7 13.3 19.9 20.9 19.4 10.9 100.0% 5,764
Floor of mouth 0.1 0.3 2.6 18.9 34.3 25.3 14.0 4.5 100.0% 2,562
Gum & other oral cavity 0.6 1.9 4.3 12.2 23.2 24.6 21.0 12.2 100.0% 6,838
Nasopharynx 3.1 6.0 13.0 24.1 26.6 16.3 8.7 2.3 100.0% 2,871
Tonsil 0.0 0.5 5.4 28.0 39.5 18.9 6.2 1.4 100.0% 9,379
Oropharynx 0.2 0.4 4.1 18.8 33.2 26.8 12.6 3.9 100.0% 1,963
Hypopharynx 0.0 0.2 1.1 16.0 33.0 28.5 16.7 4.6 100.0% 2,854
Other oral cavity & pharynx 0.3 0.8 3.1 17.7 30.2 26.0 15.0 7.0 100.0% 1,102
Digestive System: 0.2 1.1 3.5 13.4 23.8 25.0 21.8 11.1 100.0% 374,096
Esophagus 0.0 0.3 1.9 11.1 27.7 28.9 21.4 8.7 100.0% 19,680
Stomach 0.1 1.6 4.4 12.1 21.0 25.7 23.3 11.8 100.0% 33,174
Small intestine 0.1 1.6 4.7 15.7 25.5 25.9 19.0 7.5 100.0% 10,137
Colon & Rectum: 0.1 1.4 4.2 14.8 21.8 24.0 21.8 11.9 100.0% 185,758
Colon 0.1 1.2 3.6 12.5 20.1 24.6 24.2 13.8 100.0% 130,497
Rectum 0.0 1.8 5.6 20.3 26.0 22.6 16.2 7.4 100.0% 55,261
Colon & Rectum (Male) 0.1 1.4 4.1 15.6 24.2 25.7 20.1 8.8 100.0% 96,153
Colon & Rectum (Female) 0.1 1.4 4.2 14.0 19.3 22.2 23.6 15.2 100.0% 89,605
Anus, anal canal & anorectum 0.0 1.1 5.9 23.9 28.4 20.7 13.8 6.2 100.0% 8,396
Liver & intrahepatic bile duct 0.8 0.7 2.0 14.6 36.2 23.5 16.2 6.0 100.0% 39,909
Gallbladder 0.0 0.5 2.5 8.9 20.0 27.0 26.5 14.5 100.0% 5,245
Other biliary 0.1 0.6 2.4 8.3 20.2 26.6 27.3 14.4 100.0% 8,552
Pancreas 0.1 0.5 2.0 9.1 22.0 27.3 25.6 13.5 100.0% 56,166
Retroperitoneum 8.1 4.3 5.1 15.9 23.9 22.8 15.6 4.3 100.0% 1,735
Peritoneum, omentum & mesentery 0.4 1.1 1.9 10.8 24.4 32.6 22.1 6.6 100.0% 2,571
Other digestive system 0.2 0.7 2.7 10.2 21.1 24.4 27.0 13.7 100.0% 2,773
Respiratory System: 0.1 0.4 1.3 8.5 22.0 32.0 26.6 9.1 100.0% 275,140
Nose, nasal cavity & middle ear 1.6 3.7 7.3 15.3 24.3 21.4 17.8 8.7 100.0% 3,093
Larynx 0.0 0.4 2.4 14.6 30.9 29.4 17.1 5.2 100.0% 14,741
Lung & bronchus 0.0 0.2 1.1 8.1 21.5 32.4 27.4 9.3 100.0% 256,350
Lung & bronchus (Male) 0.0 0.2 1.0 7.8 22.6 33.0 26.9 8.4 100.0% 134,424
Lung & bronchus (Female) 0.0 0.3 1.3 8.5 20.2 31.7 27.8 10.2 100.0% 121,926
Pleura 2.8 2.1 4.1 8.3 17.2 21.4 26.2 17.9 100.0% 145
Trachea & other respiratory organs 17.8 18.7 8.9 10.1 15.0 14.8 9.6 5.1 100.0% 811
Bones & joints 27.0 15.4 9.2 12.2 13.1 11.8 7.8 3.7 100.0% 4,050
Soft tissue (including heart) 8.6 9.0 9.0 14.8 18.9 17.3 15.2 7.4 100.0% 15,022
Skin (excl. basal & squamous): 0.5 5.8 8.2 15.7 21.5 21.9 17.8 8.7 100.0% 107,163
Melanoma of the skin 0.5 5.9 8.4 16.2 22.1 22.0 17.1 7.9 100.0% 98,302
Other non-epithelial skin 1.3 5.3 5.9 9.4 14.7 20.4 25.7 17.3 100.0% 8,861
Breast (Female) 0.0 1.8 8.9 21.3 25.7 22.6 14.0 5.7 100.0% 304,298
Breast (Female -in situ) 0.0 0.7 10.0 27.5 27.5 22.1 10.2 2.1 100.0% 76,258
Female Genital System: 0.4 4.0 8.4 18.2 28.7 21.9 12.7 5.7 100.0% 120,411
Cervix uteri 0.1 13.9 24.3 23.7 18.4 11.2 5.7 2.7 100.0% 16,833
Corpus uteri 0.0 1.6 5.4 17.2 34.7 25.1 11.8 4.1 100.0% 62,026
Uterus, NOS 0.2 1.6 5.6 15.7 26.4 21.2 16.2 13.1 100.0% 1,905
Ovarya 1.3 3.8 6.9 18.6 24.2 21.3 15.9 8.0 100.0% 29,012
Vagina 0.9 1.9 4.7 13.4 23.9 23.1 20.6 11.6 100.0% 1,849
Vulva 0.1 1.8 6.0 15.1 20.4 20.0 21.4 15.2 100.0% 6,035
Other female genital system 0.7 5.1 4.9 14.2 25.7 25.2 17.2 7.1 100.0% 2,751
Male Genital System: 0.3 2.1 1.5 9.7 31.7 36.0 15.0 3.7 100.0% 292,787
Prostate 0.0 0.0 0.6 9.5 32.9 37.6 15.5 3.8 100.0% 278,322
Testis 6.2 50.0 22.9 13.2 5.5 1.4 0.6 0.2 100.0% 12,146
Penis 0.1 1.7 5.1 11.7 22.9 26.3 22.6 9.6 100.0% 1,739
Other male genital system 2.1 2.6 5.0 13.6 22.4 23.4 20.0 10.9 100.0% 580
Urinary System: 0.5 1.0 3.4 10.6 21.8 27.7 24.0 10.8 100.0% 164,318
Urinary bladder 0.1 0.4 1.4 6.5 18.4 28.8 29.7 14.7 100.0% 89,136
Kidney & renal pelvis 1.1 1.8 6.0 16.1 26.4 26.4 16.5 5.6 100.0% 71,374
Ureter 0.0 0.1 0.5 4.2 15.1 29.8 35.1 15.2 100.0% 2,344
Other urinary system 0.1 0.5 1.5 7.2 17.1 26.4 29.8 17.3 100.0% 1,464
Eye & Orbit 12.6 3.4 6.3 14.1 20.8 21.0 15.1 6.5 100.0% 3,758
Brain & Nervous System: 12.8 8.9 7.8 14.1 20.3 18.0 13.1 5.0 100.0% 28,642
Brain 11.9 8.8 7.6 14.0 20.6 18.4 13.6 5.1 100.0% 26,874
Cranial nerves & other nervous system 25.6 10.6 10.9 15.9 14.9 11.8 6.8 3.5 100.0% 1,768
Endocrine System: 2.8 14.5 18.7 23.3 20.3 13.3 5.7 1.4 100.0% 65,075
Thyroid 1.8 14.9 19.2 23.9 20.4 13.1 5.4 1.3 100.0% 61,797
Other endocrine & thymus 21.3 6.9 8.5 13.5 19.3 17.6 10.0 3.0 100.0% 3,278
Lymphoma: 2.9 6.9 6.7 12.7 19.9 22.5 19.7 8.6 100.0% 98,850
Hodgkin lymphoma 12.6 31.5 14.0 12.8 11.4 9.0 6.4 2.4 100.0% 11,439
Non-Hodgkin lymphoma 1.6 3.7 5.7 12.7 21.0 24.3 21.5 9.4 100.0% 87,411
Myeloma 0.0 0.6 2.9 11.0 23.2 28.6 24.3 9.3 100.0% 29,198
Leukemia: 9.3 4.5 4.9 10.1 17.6 21.8 21.0 10.9 100.0% 59,935
Lymphocytic: 14.0 2.8 3.2 9.3 18.5 22.0 20.2 10.1 100.0% 29,961
Acute lymphocytic 57.2 10.2 5.8 7.2 8.2 5.8 4.1 1.5 100.0% 7,284
Chronic lymphocytic 0.1 0.3 1.7 9.2 21.6 28.0 26.0 13.2 100.0% 20,852
Other lymphocytic 0.5 2.0 10.0 19.2 24.3 18.7 17.2 8.2 100.0% 1,825
Myeloid & Monocytic: 4.6 6.4 6.8 11.2 17.1 22.1 21.5 10.3 100.0% 27,512
Acute myeloid 5.3 6.0 5.7 10.1 16.9 23.0 22.6 10.4 100.0% 18,096
Chronic myeloid 2.2 7.4 9.3 14.1 18.0 20.2 19.1 9.7 100.0% 7,765
Acute monocytic 9.5 5.1 7.0 10.3 17.5 20.4 20.3 9.8 100.0% 975
Other myeloid & monocytic 4.3 6.7 6.5 10.5 12.9 21.4 21.7 16.0 100.0% 676
Other leukemia: 5.4 3.6 3.7 7.3 12.1 15.8 24.9 27.3 100.0% 2,462
Other acute leukemia 7.9 4.1 3.6 7.8 11.8 15.4 24.1 25.4 100.0% 1,027
Aleukemic, subleukemic & NOS 3.6 3.3 3.8 6.9 12.4 16.0 25.4 28.6 100.0% 1,435
Kaposi Sarcoma 0.4 22.9 21.5 22.0 10.4 7.9 8.3 6.5 100.0% 2,233
Mesothelioma 0.1 0.7 1.5 6.1 15.2 27.7 33.5 15.1 100.0% 4,238
Ill-defined & unspecified 0.4 0.9 2.2 8.8 18.6 22.8 26.2 20.0 100.0% 37,515

Footnotes:

Source: SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG). Percents may not sum to 100 due to rounding.

a Ovary excludes borderline cases or histologies 8442, 8451, 8462, 8472, and 8473.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.